ABSTRACT
3
PAK isoforms are known in mammals; these are closely related to PAKs found in worms and flies (1, 3, 5) . Additional species like PAK4 are Cdc42 associated but are not catalytically activated upon binding (6) because they lack a regulatory kinase inhibitory domain (KID). This inhibitory region flanking the Cdc42/Rac1 interaction/binding (CRIB) region binds to and negatively regulates the catalytic domain (7, 8, 9) . The γPAK [2] isoform contains a caspase sensitive site which results in proteolytic activation of γPAK during apoptosis (10) .
Mammalian PAKs seem to also play an important role in promoting turnover of focal complexes (FCs) and actin stress fibers (11) . In vivo inhibition of PAK results in a failure of its upstream regulators Cdc42 or Rac1 to breakdown FCs and stress fibres (7) . These effects are in part mediated by PAK inhibition of myosin light chain kinase (12) although it is also reported that PAK can exert the opposite action of directly activating type II myosin light chains (13) . PAK is also capable of driving changes in cell morphology resembling those elicited by Rac1 (14) mediated by its partner PIX, a Rac1 GEF that promotes lamellipodial formation (15) . These activities apparently derive from a requirement for PAK binding to PIX, which is in turn coupled to the important signaling protein PI-3-kinase (16, 17) .
Although basic proteins such as histone H4 and myelin basic protein (MBP) are good substrates of PAK it is unlikely these represent bone fide targets. In vitro experiments indicate that PAK is a 'basic directed' kinase, but is unusual 4 in tolerating substrates with acidic residues at the -1 position of the substrate (18). PAK was recently identified as the key kinase in regulating Ser338 of Raf1, and maximal Raf1 activation appears to be PAK-dependent (19, 20) .
Inspection of this site reveals that indeed the unusual PAK selectivity probably derives from the flanking Asp337. In addition to its effects on the actin cytoskeleton PAKs may play a role in disassembling intermediate filaments composed of desmin (21). Studies on PAK as a protease-activated kinase (22), indicated that the catalytic domain needs to undergo ATPdependent auto-transphosphorylation prior to conversion to its active form (23). The behaviour of PAK as a dimer in solution (9) suggests that transphosphorylation of the kinase can be rapid. The structure of the PAK catalytic domain-KID complex shows a substantial interface between the two (9) consistent with a measured Ki of 90 nM using PAK 83-149 (7) .
In this study, we have investigated the role of autophosphorylation sites in both Cdc42-and sphingosine-mediated PAK activation. Through the use of PAK auto-phosphorylation site substitution mutants, we show that these sites (which are largely conserved among the mammalian PAK isoforms) play distinct roles. In particular the activity of PAK is controlled not only by modification of the 'activation loop' but also by changes in the KID. were probed with affinity purified rabbit anti-αPAK antibodies as previously described (11).
The GST-PAK proteins were purified from cells lysates (as above) but glutathione-sepharose (Pharmacia) was used to trap the protein, which was subsequently released either by addition of thrombin (10 U/ml, 1 h room temperature) or with 2 column volumes of 10 mM glutathione in kinase buffer (without MBP). Purified kinase was assessed by a modified Bradford assay (Biorad) and stored at -70 o C. The integrity of the PAK proteins was assessed by SDS-PAGE. For each kinase assay 100 ng of purified PAK was incubated in 25 µl of kinase buffer under the conditions given above.
Sphingosine (Sigma) was dissolved in dimethylsulphoxide (DMSO) at 10 mg/ml and stored at -40 o C. Kinase assays were performed either in kinase buffer + 20% DMSO or using sphingosine vesicles obtained by sonicating sphingosine (1 mg/ml) in PBS immediately prior to the experiment.
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For phosphopeptide identification (Fig.1A) 10 µg of purified βPAK was incubated with 10 µg GST/Cdc42.GTPγS in 50 µl kinase buffer containing 5 µM
[γ33ATP] at 32 o C for 10 min, followed by addition of 'cold' ATP to 500 µM and further incubation for 30 min to ensure complete autophosphorylation.
Phosphoamino acid analysis, tryptic digestion, HPLC analysis and peptide microsequencing are as previously described (11).
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RESULTS
Conserved autophosphorylation sites among different PAK isoforms.
Cdc42-mediated αPAK activation in vitro is accompanied by autophosphorylation of recombinant αPAK on 6 serine residues in the Nterminal regulatory domain and 1 threonine residue within the catalytic domain (11) . The γPAK isoform was found to be phosphorylated on all equivalent sites, but additionally S19 and S165 were phosphorylated (24). We were interested to test the other PAK isoform (βPAK/PAK3) particularly with a view to identifying the primary autophosphorylation events. The βPAK was purified from transiently transfected COS7 cells and activated in the presence of excess Cdc42.GTPγS (see methods) but limiting ATP concentration; 2µM kinase was incubated with 5µM [γ33P]ATP (followed by phosphorylation to completion in 500 µM ATP). Fig. 1A shows the profile of HPLC separated βPAK tryptic peptides: radiolabelled residues (asterisks) were then determined from 33P release during the sequencing cycles. The results indicate that the initial phosphorylation events in βPAK occur at residues S50, S139 and T421, corresponding to S57, S144 and T422 in αPAK (Fig. 1B) .
The limited number of autophosphorylation sites identified in this analysis reflects differential rates of autophosphorylation of the potential sites at limiting ATP concentration: more weakly labeled peptides were not subjected to further analysis.
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In γPAK as with αPAK, all the non-kinase autophosphorylation sites are serine residues (see Fig. 1B ), however γPAK S19 (equivalent to αPAK T20) was found to be phosphorylated to the same extent as γPAKS20 (24). We have recently shown the latter site to be important for the regulation of Nck SH3
binding (25). Since mutant αPAK(T422S) is activated normally by Cdc42-GTPγS, but no phospho-threonine is detected ( Fig. 2A) is seems αPAK T20 is not an autophosphorylation site. This mutagenesis was performed in the L404S background which allows for recovery of E. coli expressed kinase with low basal activity (11) .
The contribution of T422 phosphorylation to PAK activation.
Previous studies have shown that activation of the catalytic domain requires phosphorylation of the residue equivalent to αPAK T422, probably in 'trans' (23,26). However although the T422A mutant exhibited minimal activity towards substrate, it underwent robust auto-phosphorylation with Cdc42-GTPγS ( Fig. 2A) . Since myelin basic protein is not a known physiological PAK substrate we carried out an additional experiment using three other substrates: myosin light chain (13), the MEKK2(1-290) regulatory region and GIT1(1-376), the latter 90 kDa protein is strongly phosphorylated in the PAK/PIX/GIT complex (16) . The T422A mutant was defective in phosphorylation of all three substrates demonstrating that although T422 phosphorylation is not required for the primary (intramolecular) 10 autophosphorylation events it has a strong influence on substrate recognition.
Mutants were also generated in the wildtype αPAK background. In this case the wildtype PAK protein undergoes activation in the bacteria and is recovered in an autophosphorylated state. Comparing the level of activity of the T422A mutant with two other mutants substituted in the N-terminal region (S144/149A and S198/203A) it was clear that T422 is not the only autophosphorylation site that can affect activity (Fig. 2B ). To test in vivo the notion that T422 phosphorylation is not the sole determinant of PAK activity, the doubly substituted αPAK(L107F, T422A), which lacks a functional kinase inhibitory domain (KID), was compared with αPAK(L107F). The kinase was expressed and immuno-precipitated from transiently transfected HeLa cells.
As can be seen in Fig. 3A , and in contrast with results using recombinant PAK, the T422A substitution reduces activity of the αPAK(L107F) protein by only ~50%. Thus phosphorylation events in the N-terminus, as indicated by the significant mobility shift of the αPAK(L107F, T422A), clearly can play roles in activating PAK in vivo although cellular phosphatases probably more effectively down-regulate the double mutant as judged by the extent of the mobility shift compared with αPAK(L107F).
A conserved serine in the KID modulates PAK activity.
To investigate further the role of individual autophosphorylation sites, additional α and βPAK mutants were generated in which the respective 11 serine and threonine were changed to alanine. The closely spaced sites in αPAK (S144/149 and S198/203) were substituted together. We did not analyze S21 (within the Nck binding site) since PAK lacking this Nck-binding domain behaved identically to full-length kinase in terms of in vitro activation (data not shown). cDNAs encoding these mutnats were transfected into HeLa cells and the resulting GST/PAK fusion proteins purified, and quantified by coomassie staining (Fig. 3B ). All the proteins were recovered with similar yields and no breakdown was detected on western analysis (not shown).
To analyse these PAK mutants during activation in vivo, the cDNAs were cotransfected with an expression plasmid for Cdc42 G12V . Under these conditions the smaller Cdc42 G12V protein was expressed in molar excess over PAK (data not shown). Fig. 3C shows the activity of each mutant expressed relative to that of wildtype αPAK (activity designated 100%). The αPAK S57A and αPAK S198/203A mutants were activated to the same extent as wild type αPAK, while the purified S144/149A kinase was less active. Similarly purified βPAK mutants βPAK S50A and βPAK S200A were as active as wildtype indicating these residues play no direct role in kinase activation. The βPAK S139A and βPAK
T421A
proteins (equivalent to αPAK S144A or T422A) were activated by Cdc42 G12V to a lesser extent than wildtype implicating both these sites in the activation process. The double αPAK S144/149A mutant was somewhat less active than the single βPAK S139A mutant (but βPAK does not contain a site corresponding to αPAK S149). These results are in agreement with those obtained by in vitro 9A ). This explains why phosphorylation of αPAK S144 or 13 the corresponding βPAK S139 plays a direct role in modulating kinase activity.
Sphingosine activation of αPAK.
Both PAK1 autophosphorylation and 'in gel' activity towards a p47phox
peptide have been reported to be stimulated by various sphingo-lipids (27).
Sphingosine is relatively selective since closely related compounds are ineffective in activating PAK, suggesting a specific interaction with the kinase. Stimulation of αPAK activity in vitro was half maximal at ~500 µM sphingosine (Fig.5A ). αPAK activation was poorer at higher concentrations of sphingosine (> 1mM). This inhibitory effect of sphingosine at higher concentrations was demonstrated when pre-activated αPAK was tested at 5 mM sphingosine indicating a direct inhibition of catalysis rather than the activation process ( Fig. 5B right panel) .
Sphingosine-and Cdc42-mediated PAK activation through distinct sites.
The αPAK inhibitor polypeptide (residues 83-148) was similarly effective in blocking both sphingosine-and Cdc42-mediated activation of αPAK in vitro (Fig. 6A) . Thus sphingosine relieves autoinhibitory interactions within PAK by affecting the inhibitor/kinase interface -though apparently it does not directly bind at the interface (otherwise it should similarly neutralize the inhibitor Differences in (tryptic) autophosphorylation profiles with the two activators (26) could reflect masking of N-terminal sites (perhaps S144 and S149) by sphingosine or preferential inhibition of the kinase towards some autophosphorylation sites. mutants (7) which cannot bind GTPγS.Cdc42 were activated normally by sphingosine ( Fig. 8A and B) .
DISCUSSION
PAK autophosphorylation and regulation of kinase function.
Since PAK is auto-phosphorylated at several sites it is pertinent to ask what specific roles these might play. Here we have shown with both α-and βPAK that two conserved sites are key to regulating activity. The αPAK T422
(within the catalytic domain) and a S144 flanking the kinase inhibitor region play distinct but complementary roles. Substitution of the autophosphorylated T422 by aspartic acid can render the αPAK kinase constitutively active in vivo though not fully active by in vitro criteria (11).
However substitution of the N-terminal autophosphorylation sites with acidic residues leads to proteins which are unstable in vivo (data not shown).
There have been several previous investigations of differential PAK autophosphorylation under various activation conditions. An analysis using γPAK concluded that there were significant differences between auto-16 phosphorylation with Mg.ATP alone compared with events occurring in the presence of Cdc42 (24). Interestingly it was observed that Cdc42.GTPγS drives specific phosphorylation of Ser141, and Ser165, and a higher levels of Thr402 phosphorylation. This γPAK S141 (analogous to αPAK S144) forms part of the kinase inhibitory domain (KID) that appears to be accessible only when Cdc42.GTP is bound. Upon phosphorylation this then prevents the KID packing against the kinase domain (Fig. 9A) . When T422 is subsequently trans-phosphorylated this in turn prevents catalytic domain interaction with the KID (illustrated in Fig. 9B ). These multiple events may be designed to ensure that the kinase switches from inactive to active state only under specific conditions.
The autophosphorylation of the regulatory threonine, T402 γPAK parallels activity of the kinase, suggesting that this threonine autophosphorylation event is closely coupled to the activation process (29) What is the purpose of having a 2-step activation process? We envision binding of Cdc42.GTP or Rac.GTP to structurally modify the inhibitory domain allowing first autophosphorylation of αPAK N-terminus including S144 (or equivalent residues for other isoforms). Since αPAK exists as a dimer (9) T422 transphosphorylation should be relatively efficient (Fig. 9B) . If Nck and PIX are bound (16, 32) it is likely that phosphorylation of the sites S21, S198 and S203 would be impaired. However, even following dissociation of the GTPase, the kinase would remain in an 'open' state allowing the intermolecular activation of PAK by phosphorylation of T422 to occur.
Alternatively other kinases including PDK1 might carry out phosphorylation of the activation loop (31).
Mechanisms underlying PAK activation in vivo.
It is already established that integrin-dependent cell-matrix interactions promote activation of Rac1 and Cdc42 and thus PAK (33, 34) . The kinase in turn is coupled to PIX and PI-3kinase (17 
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